Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer, Roche, AstraZeneca: Emerging Markets Earnings Roundup (Part 3)

Feb 18 2011

• By PharmAsia News

Related Content

Roche Looks Ahead To 2011, But Avastin Woes And Other Concerns Could Pose Challenges

Feb 02 2011

AstraZeneca, GlaxoSmithKline, Merck: Emerging Markets Earnings Roundup (Part 2 of 3)

Aug 06 2010

Roche Launches Avastin In China For Colon And Rectal Cancer Following Counterfeit Drug Incident In Shanghai

Sep 30 2010

MNCs Need China-Oriented Oncology Strategy Mixed With Pricing Know-how

Dec 14 2010

As Pfizer Deal Speeds Up, Aurobindo Tangos With AstraZeneca For Branded Generics Play In Emerging Markets

Sep 07 2010

Sanofi-Aventis Emerging Markets Sales Exceed U.S., Europe: Emerging Markets Earnings Round Up (Part 2)

Feb 11 2011

AstraZeneca, Pfizer, GlaxoSmithKline: Emerging Markets Earnings Roundup (Part 2 of 2)

Dec 23 2010

For Pfizer Chief, The First Order Of Business Is Research

Feb 01 2011

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window